{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:49:30Z","timestamp":1784360970109,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.chi.0000166986.30592.67","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T07:04:14Z","timestamp":1121151854000},"page":"748-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Comparison of Risperidone and Methylphenidate for Reducing ADHD Symptoms in Children and Adolescents With Moderate Mental Retardation"],"prefix":"10.1016","volume":"44","author":[{"given":"Alceu Gomes","family":"Correia Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bodanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Laufer","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Paglioza","family":"Alvares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Augusto","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.chi.0000166986.30592.67_bib1","series-title":"Manual for the Child Behavior Checklist 4-18 and 1991 Profile","author":"Achenbach","year":"1991"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00004583-199307000-00022","article-title":"Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects","volume":"32","author":"Aman","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib5","first-page":"253","article-title":"Atypical antipsychotics in persons with developmental disabilities","volume":"5","author":"Aman","year":"1999","journal-title":"MRDD Res Rev"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00004583-199103000-00013","article-title":"Clinical effects of methylphenidate and thioridazine in intellectually subaverage children","volume":"30","author":"Aman","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","article-title":"The Nisonger CBRF: a child behavior rating form for children with developmental disabilities","volume":"17","author":"Aman","year":"1996","journal-title":"Res Dev Disabil"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/104454603321666171","article-title":"Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies","volume":"13","author":"Aman","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12 suppl","key":"10.1097\/01.chi.0000166986.30592.67_bib9","first-page":"5S","article-title":"Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid disorders","volume":"38","author":"American Academy of Child and Adolescent Psychiatry","year":"1999","journal-title":"J Am Acad Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib10","series-title":"Diagnostic and Statistical Manual of Mental Disorder, 4th edition (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib11","series-title":"Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook","first-page":"229","article-title":"Stimulants","author":"Arnold","year":"1998"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","article-title":"Side effects of methylphenidate in children with attention deficits hyperactivity disorder: a systematic, placebo-controlled evaluation","volume":"86","author":"Barkley","year":"1990","journal-title":"Pediatrics"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib13","first-page":"40","article-title":"Side effects profile of new antipsychotic agents","volume":"57","author":"Casey","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib14","series-title":"Statistical Power Analyses for the Behavioral Sciences","author":"Cohen","year":"1998"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"A long-term open-label study of risperidone in children with severe disruptive behaviors and subaverage IQ","volume":"161","author":"Findling","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00004583-199908000-00011","article-title":"Risperidone treatment for juvenile bipolar disorder: a retrospective chart review","volume":"38","author":"Frazier","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.149.1.68","article-title":"Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects","volume":"149","author":"Gilberg","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1542\/peds.86.6.922","article-title":"Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder","volume":"86","author":"Handen","year":"1990","journal-title":"Pediatrics"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004583-199205000-00011","article-title":"Effects and non effects of methylphenidate in children with mental retardation and ADHD","volume":"31","author":"Handen","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004583-199103000-00012","article-title":"Adverse side effects of methylphenidate among mentally retarded children with ADHD","volume":"30","author":"Handen","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00004583-199907000-00009","article-title":"Efficacy if methylphenidate among preschool children with developmental disabilities and ADHD","volume":"38","author":"Handen","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00004583-199410000-00014","article-title":"Prediction of response to methylphenidate among children with ADHD and mental retardation","volume":"33","author":"Handen","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00004583-200111000-00006","article-title":"Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD","volume":"40","author":"James","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/01454455940184005","article-title":"Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation","volume":"18","author":"Johnson","year":"1994","journal-title":"Behav Modif"},{"issue":"suppl 334","key":"10.1097\/01.chi.0000166986.30592.67_bib25","first-page":"81","article-title":"The UKU side effect rating scale","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib26","first-page":"737","article-title":"Psychiatric interviews suitable for use in research with children and adolescents","volume":"21","author":"Orvaschel","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00004583-198909000-00019","article-title":"Treatment of ADDH in mentally retarded children: a preliminary study","volume":"28","author":"Payton","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.chi.0000120024.14101.96","article-title":"Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response","volume":"43","author":"Pearson","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004583-200302000-00015","article-title":"Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD","volume":"42","author":"Pearson","year":"2003","journal-title":"J Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S1516-44462003000200007","article-title":"Inter reliability for the Schedule for Affective Disorders and Schizophrenia, Epidemiological Version for school age children (K-SADS-E)","volume":"25","author":"Polanczyk","year":"2003","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00004583-200209000-00014","article-title":"ADHD in a developing country: Are DSM-IV criteria suitable for culturally different populations?","volume":"41","author":"Rohde","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1207\/s15374424jccp2704_4","article-title":"Factors influencing elementary school teachers' rating ADHD and ODD behaviors","volume":"27","author":"Stevens","year":"1998","journal-title":"J Clin Child Psychol"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","article-title":"Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment","volume":"40","author":"Swanson","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/peds.110.3.e34","article-title":"Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/104454601750143384","article-title":"Long-term effects of stimulants medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder","volume":"11","author":"Vitiello","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib37","series-title":"Manual for the Wechsler Intelligence Scale for Children","author":"Wechsler","year":"1991"},{"key":"10.1097\/01.chi.0000166986.30592.67_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0193-953X(18)30265-X","article-title":"The stimulants","volume":"15","author":"Wilens","year":"1992","journal-title":"Psychiatr Clin North Am"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:18:39Z","timestamp":1760192319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709617354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0890856709617354"],"URL":"https:\/\/doi.org\/10.1097\/01.chi.0000166986.30592.67","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Risperidone and Methylphenidate for Reducing ADHD Symptoms in Children and Adolescents With Moderate Mental Retardation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/01.chi.0000166986.30592.67","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}